Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: February 6, 2025
Reporting Period: Fiscal quarter ended December 31, 2024
Context: The Company issued a press release announcing preliminary unaudited selected financial results for the quarter. The Company is an emerging growth company.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) containing the actual financial data. The text of this 8-K does not provide specific values for:
- Revenue
- Profit or Net Income
- Cash Flow
- Margins
- Debt Levels
- Liquidity Positions
Note: Specific financial figures are not present in the source text provided.
Material Changes
The filing text does not contain comparative data or specific details regarding material changes versus the prior comparable period. Investors must refer to the referenced press release (Exhibit 99.1) for year-over-year or quarter-over-quarter analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of preliminary unaudited results but does not include forward-looking guidance, outlook statements, or specific management commentary within the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this document. The filing includes a standard disclaimer stating that the information is not "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 6, 2025) for the actual preliminary financial figures.
- Verify the unaudited nature of the reported results for the quarter ended December 31, 2024.
- Confirm the Company's status as an emerging growth company and any associated reporting implications.
- Check for subsequent filings that may provide audited results or updated guidance.